系统性硬化症患者社交外貌焦虑量表的验证:硬皮病以患者为中心的干预网络队列研究
本研究在硬皮病以患者为中心的干预网络队列的938例系统性硬化症患者中验证社交外貌焦虑量表(SAAS)的结构效度、内部一致性信度、聚合效度和跨疾病亚型的测量等价性。验证性因子分析支持单因子结构,多组验证性因子分析显示标量不变性模型拟合最佳,总量表内部一致性信度良好(α=0.96),且SAAS评分与体像不满、负面评价恐惧、社交焦虑和抑郁等测量呈聚合效度证据。结论认为SAAS可可靠且有效地评估系统性硬化症患者的外貌评价恐惧,其评分可在疾病亚型间进行有意义的比较。
要点
- 验证性因子分析支持SAAS单因子结构,比较拟合指数0.92,标准化残差均方根0.04,近似误差均方根0.08。
- 总量表内部一致性信度良好(α=0.96),各疾病亚组内亦良好。
- 多组验证性因子分析显示标量不变性模型拟合最佳,SAAS评分可在局限型和弥漫型亚型间比较。
核心结论
- SAAS可可靠且有效地评估系统性硬化症患者的外貌评价恐惧,其评分可在疾病亚型间进行有意义的比较。
研究设计与样本
- 硬皮病以患者为中心的干预网络队列研究,纳入938例系统性硬化症患者,完成SAAS及外貌相关担忧和心理困扰测量。
- 采用验证性因子分析检验结构效度,多组验证性因子分析检验局限型与弥漫型亚型间的测量等价性,Cronbach's alpha检验内部一致性信度,并与体像不满、负面评价恐惧、社交焦虑和抑郁测量的相关性检验聚合效度。
主要发现
- 验证性因子分析支持单因子结构(比较拟合指数0.92,标准化残差均方根0.04,近似误差均方根0.08)。
- 多组验证性因子分析显示标量不变性模型最佳拟合数据。
- 总量表内部一致性信度良好(α=0.96),疾病亚组内亦良好。
- SAAS评分与体像不满、负面评价恐惧、社交焦虑和抑郁测量之间总体存在聚合效度证据。
关键数值与推荐
- SAAS单因子结构拟合指标:比较拟合指数0.92,标准化残差均方根0.04,近似误差均方根0.08。
- 总量表Cronbach's alpha为0.96。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic sclerosis (SSc) is an autoimmune disease that can cause disfiguring changes in appearance. This study examined the structural validity, internal consistency reliability, convergent validity, and measurement equivalence of the Social Appearance Anxiety Scale (SAAS) across SSc disease subtypes. METHODS: Patients enrolled in the Scleroderma Patient-centered Intervention Network Cohort completed the SAAS and measures of appearance-related concerns and psychological distress. Confirmatory factor analysis (CFA) was used to examine the structural validity of the SAAS. Multiple-group CFA was used to determine whether SAAS scores can be compared across patients with limited and diffuse disease subtypes. Cronbach's alpha was used to examine internal consistency reliability. Correlations of SAAS scores with measures of body image dissatisfaction, fear of negative evaluation, social anxiety, and depression were used to examine convergent validity. SAAS scores were hypothesized to be positively associated with all convergent validity measures, with correlations significant and moderate to large in size. RESULTS: A total of 938 patients with SSc were included. CFA supported a 1-factor structure (Comparative Fit Index 0.92, Standardized Root Mean Residual 0.04, and Root Mean Square Error of Approximation 0.08), and multiple-group CFA indicated that the scalar invariance model best fit the data. Internal consistency reliability was good in the total sample (α = 0.96) and in disease subgroups. Overall, evidence of convergent validity was found with measures of body image dissatisfaction, fear of negative evaluation, social anxiety, and depression. CONCLUSION: The SAAS can be reliably and validly used to assess fear of appearance evaluation in patients with SSc, and SAAS scores can be meaningfully compared across disease subtypes.
引用
- Mills SD, Kwakkenbos L, Carrier ME, et al. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Arthritis Care Res (Hoboken). 2018. PMID: 29342510. doi:10.1002/acr.23514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。